Lipikind-AS 10 Capsules

babies: it does not apply to babies. lactating mothers: it is unsafe to use in lactating mothers.
consult the doctor. pregnancy: it is unsafe to use during pregnancy.
consult the doctor. driving: it is unsafe to use before driving as it may cause dizziness.
alcohol: it is unsafe to consume alcohol with this medicine. consult the doctor.
liver: this capsule should be used with caution in patients with liver disease. you may require dose adjustment.
it is not recommended for severe liver disease. consult the doctor before using this medication. kidney: this capsule should be used with caution in patients with kidney disease.
you may require dose adjustment. it is not recommended for severe kidney disease.
consult the doctor before using this medication. .

Abdominal pain Constipation Flatulence Increased liver enzymes Hepatitis Reye's syndrome like symptoms.

LIPIKIND AS capsules will help in preventing heart attack and stroke. atorvastatin is a lipid-lowering agent that blocks the enzyme which is required to make cholesterol in the body.
it lowers the bad cholesterol, triglycerides and increases good cholesterol. aspirin has an antiplatelet action.
it prevents the platelets from aggregation and reduces the chances of forming blood clots..

If you miss a dose, take LIPIKIND AS as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• LIPIKIND AS is used to lower your risk of heart attack and stroke. • take it with food to avoid stomach upset. • Inform the doctor if you experience muscle pain, weakness, fever and dark urine..

• (aspirin + atorvastatin) + cyclosporine: concurrent use may lead to increase the toxicity of atorvastatin • (aspirin + atorvastatin) + gemfibrozil: concurrent use may lead to increase the toxicity of atorvastatin • (aspirin + atorvastatin) + ionafarnib: concurrent use may lead to increase the toxicity of atorvastatin • (aspirin + atorvastatin) + tipranavir: concurrent use may lead to increase the toxicity of atorvastatin.